Ignite Creation Date:
2025-12-24 @ 7:07 PM
Ignite Modification Date:
2026-02-18 @ 2:47 AM
Study NCT ID:
NCT02789657
Status:
COMPLETED
Last Update Posted:
2022-05-19
First Post:
2016-05-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Neoadjuvant Therapy in Clinical Stage I-III HER2-positive Breast Cancer.
Sponsor:
Brown University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
BrUOG 308
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None